Friday, May 20, 2022

Opening Discussion Topic:

Is the Healthcare Market Still Hot?

For starters, Healthcare M&A was up 16% in 2021, and value rose 44% over 2020, according to Bain & Co., for a total deal value of $440 billion across pharma, medtech, payers, providers, and healthcare services. Even more impressive, deal multiples reached the highest level in decades: an average of 20 times forward-looking enterprise value (EV/EBITDA). So, what’s happening now? After we’ve heard your take on the market, our Featured Guest Member, Mike McKinnon, Partner in the Corporate Practice Group of Sheppard Mullin, will share his “ringside seat perspective” from the deal arena representing PE funds, VCs, and portfolio companies.

Following his presentation, Mike has some very provocative questions for us to discuss, particularly in light of the hit some very hot healthcare stocks, like Teladoc, have taken lately. So, RSVP today!

Mike McKinnon, Partner in the Corporate Practice Group of Sheppard Mullin, has
spent his entire legal career focused on corporate and securities law, with an emphasis on M&A, joint ventures, and equity and debt financings in the healthcare and life sciences industries. He has assisted clients in acquiring or investing in medical device, home infusion, diagnostic imaging, medical groups, physician practices, surgery centers, PPO networks, diabetic supplies, urgent care, and clinical trial companies.

May 20……Jun 17……Jul 15……Aug 19……Sep 16……Oct 21……Nov 18……*Dec 7 combined with OC

Our Los Angeles Healthcare Round Table meets (via Zoom or sometimes with an In-Person option) on the third Friday of each month (*unless a holiday or special event alters the date).

Past Meeting Information